{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:56:13Z","timestamp":1790632573873,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Nutricia Metabolics Young Investigator Grant 2019"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Nutr"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Glycogen storage disease type Ia (GSDIa) is an inborn metabolic disorder caused by the deficiency of glucose-6-phospatase-\u03b1 (G6Pase-\u03b1) leading to mitochondrial dysfunction. It remains unclear whether mitochondrial dysfunction is present in patients\u2019 peripheral blood mononuclear cells (PBMC) and whether dietary treatment can play a role. The aim of this study was to investigate mitochondrial function in PBMC of GSDIa patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Ten GSDIa patients and 10 age-, sex- and fasting-time matched controls were enrolled. Expression of genes involved in mitochondrial function and activity of key fatty acid oxidation (FAO) and Krebs cycle proteins were assessed in PBMC. Targeted metabolomics and assessment of metabolic control markers were also performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Adult GSDIa patients showed increased <jats:italic>CPT1A<\/jats:italic>, <jats:italic>SDHB<\/jats:italic>, <jats:italic>TFAM<\/jats:italic>, <jats:italic>mTOR<\/jats:italic> expression (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) and increased VLCAD, CPT2 and citrate synthase activity in PBMC (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). VLCAD activity directly correlated with WC (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), BMI (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), serum malonycarnitine levels (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). CPT2 activity directly correlated with BMI (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Mitochondrial reprogramming is detectable in PBMC of GSDIa patients. This feature may develop as an adaptation to the liver enzyme defect and may be triggered by dietary (over)treatment in the frame of G6Pase-\u03b1 deficiency. PBMC can represent an adequate mean to assess (diet-induced) metabolic disturbances in GSDIa.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12263-023-00729-y","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T19:15:24Z","timestamp":1686078924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia"],"prefix":"10.1186","volume":"18","author":[{"given":"Alessandro","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Assunto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Ruoppolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Caterino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pirozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Strisciuglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Parenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,6]]},"reference":[{"issue":"7","key":"729_CR1","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/humu.20772","volume":"29","author":"JY Chou","year":"2008","unstructured":"Chou JY, Mansfield BC. Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease. Hum Mutat. 2008;29(7):921\u201330.","journal-title":"Hum Mutat"},{"issue":"11","key":"729_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/gim.2014.128","volume":"16","author":"PS Kishnani","year":"2014","unstructured":"Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A, et al. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics. Genet Med. 2014;16(11):e1.","journal-title":"Genet Med"},{"issue":"Suppl 1","key":"729_CR3","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1007\/BF02680007","volume":"161","author":"JP Rake","year":"2002","unstructured":"Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP, European Study on Glycogen Storage Disease Type I (ESGSD I). Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr. 2002;161(Suppl 1):S112-9.","journal-title":"Eur J Pediatr."},{"issue":"11","key":"729_CR4","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.3390\/nu13113828","volume":"13","author":"TGJ Derks","year":"2021","unstructured":"Derks TGJ, Rodriguez-Buritica DF, Ahmad A, de Boer F, Couce ML, Gr\u00fcnert SC, et al. Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs. Nutrients. 2021;13(11):3828.","journal-title":"Nutrients"},{"issue":"1","key":"729_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0344-0338(80)80185-3","volume":"167","author":"UN Riede","year":"1980","unstructured":"Riede UN, Spycher MA, Gitzelmann R. Glycogenosis type I (glucose 6-phosphatase deficiency): I. Ultrastructural morphometric analysis of juvenile liver cells. Pathol Res Pract. 1980;167(1):136\u201350.","journal-title":"Pathol Res Pract"},{"issue":"7","key":"729_CR6","doi-asserted-by":"publisher","first-page":"44408","DOI":"10.1038\/srep44408","volume":"20","author":"BL Farah","year":"2017","unstructured":"Farah BL, Sinha RA, Wu Y, Singh BK, Lim A, Hirayama M, et al. Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa). Sci Rep. 2017;20(7):44408.","journal-title":"Sci Rep"},{"key":"729_CR7","doi-asserted-by":"publisher","first-page":"579981","DOI":"10.3389\/fendo.2020.579981","volume":"11","author":"L Hannibal","year":"2020","unstructured":"Hannibal L, Theimer J, Wingert V, et al. Metabolic Profiling in Human Fibroblasts Enables Subtype Clustering in Glycogen Storage Disease. Front Endocrinol (Lausanne). 2020;11:579981 Published 2020 Nov 23.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7\u20138","key":"729_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.15690\/vramn.v69i7-8.1112","volume":"69","author":"OV Kurbatova","year":"2014","unstructured":"Kurbatova OV, Izmailova TD, Surkov AN, Namazova-Baranova LS, Poliakova SI, Miroshkina LV, et al. Mitochondrial dysfunction in children with hepatic forms of glycogen storage disease. Vestn Ross Akad Med Nauk. 2014;69(7\u20138):78\u201384.","journal-title":"Vestn Ross Akad Med Nauk"},{"issue":"6","key":"729_CR9","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s10545-018-0149-4","volume":"41","author":"A Rossi","year":"2018","unstructured":"Rossi A, Ruoppolo M, Formisano P, Villani G, Albano L, Gallo G, Crisci D, Moccia A, Parenti G, Strisciuglio P, Melis D. Insulin-resistance in glycogen storage disease type Ia: linking carbohydrates and mitochondria? J Inherit Metab Dis. 2018;41(6):985\u201395.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"729_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s13023-019-1223-1","volume":"14","author":"A Assunto","year":"2019","unstructured":"Assunto A, Ferrara U, De Luca A, Pivonello C, Lombardo L, Piscitelli A, et al. Isoform-specific NF1 mRNA levels correlate with disease severity in Neurofibromatosis type 1. Orphanet J Rare Dis. 2019;14(1):261.","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"729_CR11","doi-asserted-by":"publisher","first-page":"e45429","DOI":"10.1371\/journal.pone.0045429","volume":"7","author":"S Tucci","year":"2012","unstructured":"Tucci S, Herebian D, Sturm M, Seibt A, Spiekerkoetter U. Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-\/-) mouse to compensate a defective fatty acid \u03b2-oxidation. PLoS ONE. 2012;7(9):e45429.","journal-title":"PLoS ONE"},{"issue":"6","key":"729_CR12","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s10545-018-0245-5","volume":"41","author":"J Hesse","year":"2018","unstructured":"Hesse J, Braun C, Behringer S, Matysiak U, Spiekerkoetter U, Tucci S. The diagnostic challenge in very-long chain acyl-CoA dehydrogenase deficiency (VLCADD). J Inherit Metab Dis. 2018;41(6):1169\u201378.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"729_CR13","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/jimd.12098","volume":"42","author":"S Tucci","year":"2019","unstructured":"Tucci S, Behringer S, Sturm M, Gr\u00fcnert SC, Spiekerkoetter U. Implementation of a fast method for the measurement of carnitine palmitoyltransferase 2 activity in lymphocytes by tandem mass spectrometry as confirmation for newborn screening. J Inherit Metab Dis. 2019;42(5):850\u20136.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"729_CR14","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/jimd.12368","volume":"44","author":"S Tucci","year":"2021","unstructured":"Tucci S, Wagner C, Gr\u00fcnert SC, Matysiak U, Weinhold N, Klein J, Porta F, Spada M, Bordugo A, Rodella G, Furlan F, Sajeva A, Menni F, Spiekerkoetter U. Genotype and residual enzyme activity in medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: Are predictions possible? J Inherit Metab Dis. 2021;44(4):916\u201325.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"729_CR15","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1039\/C4MB00729H","volume":"11","author":"E Scolamiero","year":"2015","unstructured":"Scolamiero E, Cozzolino C, Albano L, Ansalone A, Caterino M, Corbo G, et al. Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism. Mol BioSyst. 2015;11(6):1525\u201335.","journal-title":"Mol BioSyst"},{"issue":"12","key":"729_CR16","doi-asserted-by":"publisher","first-page":"E4211","DOI":"10.3390\/ijms21124211","volume":"21","author":"V De Pasquale","year":"2020","unstructured":"De Pasquale V, Caterino M, Costanzo M, Fedele R, Ruoppolo M, Pavone LM. Targeted Metabolomic Analysis of a Mucopolysaccharidosis IIIB Mouse Model Reveals an Imbalance of Branched-Chain Amino Acid and Fatty Acid Metabolism. Int J Mol Sci. 2020;21(12):E4211.","journal-title":"Int J Mol Sci"},{"key":"729_CR17","doi-asserted-by":"crossref","unstructured":"Villani GR, Gallo G, Scolamiero E, Salvatore F, Ruoppolo M. \u201cClassical organic acidurias\u201d: diagnosis and pathogenesis. Clin Exp Med. 2017;17(3):305\u201323.","DOI":"10.1007\/s10238-016-0435-0"},{"issue":"10","key":"729_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13023-015-0301-2","volume":"29","author":"D Melis","year":"2015","unstructured":"Melis D, Rossi A, Pivonello R, Salerno M, Balivo F, Spadarella S, et al. Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation. Orphanet J Rare Dis. 2015;29(10):91.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"729_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13023-020-01377-w","volume":"15","author":"A Rossi","year":"2020","unstructured":"Rossi A, Simeoli C, Salerno M, Ferrigno R, Della Casa R, Colao A, Strisciuglio P, Parenti G, Pivonello R, Melis D. Imbalanced cortisol concentrations in glycogen storage disease type I: evidence for a possible link between endocrine regulation and metabolic derangement. Orphanet J Rare Dis. 2020;15(1):99.","journal-title":"Orphanet J Rare Dis"},{"issue":"Supplement 1","key":"729_CR20","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/S1096-7192(22)00211-6","volume":"136","author":"H Saavedra","year":"2022","unstructured":"Saavedra H, Yu A, Rodriguez-Buritica DF. The use of alanine, free carnitine and IGFBP-1 as potential biomarkers for glycogen storage disease type I. Mol Genet Metab. 2022;136(Supplement 1):S18 ISSN 1096-7192.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"729_CR21","doi-asserted-by":"publisher","first-page":"861","DOI":"10.4161\/cc.10.6.14930","volume":"10","author":"GA Soliman","year":"2011","unstructured":"Soliman GA. The integral role of mTOR in lipid metabolism. Cell Cycle. 2011;10(6):861\u20132.","journal-title":"Cell Cycle"},{"issue":"3","key":"729_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/embor.2013.5","volume":"14","author":"SJ Ricoult","year":"2013","unstructured":"Ricoult SJ, Manning BD. The multifaceted role of mTORC1 in the control of lipid metabolism. EMBO Rep. 2013;14(3):242\u201351.","journal-title":"EMBO Rep"},{"issue":"50","key":"729_CR23","doi-asserted-by":"publisher","first-page":"50428","DOI":"10.1074\/jbc.M310130200","volume":"278","author":"S Gobin","year":"2003","unstructured":"Gobin S, Thuillier L, Jogl G, Faye A, Tong L, Chi M, et al. Functional and structural basis of carnitine palmitoyltransferase 1A deficiency. J Biol Chem. 2003;278(50):50428\u201334.","journal-title":"J Biol Chem"},{"key":"729_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","volume":"78","author":"SM Houten","year":"2016","unstructured":"Houten SM, Violante S, Ventura FV, Wanders RJ. The Biochemistry and Physiology of Mitochondrial Fatty Acid \u03b2-Oxidation and Its Genetic Disorders. Annu Rev Physiol. 2016;78:23\u201344.","journal-title":"Annu Rev Physiol"},{"issue":"Suppl 1","key":"729_CR25","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1007\/BF02679998","volume":"161","author":"RH Bandsma","year":"2002","unstructured":"Bandsma RH, Smit GP, Kuipers F. Disturbed lipid metabolism in glycogen storage disease type 1. Eur J Pediatr. 2002;161(Suppl 1):S65\u20139.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"729_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000283242","volume":"56","author":"AM Das","year":"2010","unstructured":"Das AM, L\u00fccke T, Meyer U, Hartmann H, Illsinger S. Glycogen storage disease type 1: impact of medium-chain triglycerides on metabolic control and growth. Ann Nutr Metab. 2010;56(3):225\u201332.","journal-title":"Ann Nutr Metab"},{"key":"729_CR27","doi-asserted-by":"crossref","unstructured":"Gjorgjieva M, Oosterveer MH, Mithieux G, Rajas F. Mechanisms by Which Metabolic Reprogramming in GSD1 Liver Generates a Favorable Tumorigenic Environment. JIEMS. 2016.","DOI":"10.1177\/2326409816679429"},{"key":"729_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.molmet.2018.07.006","volume":"16","author":"L Monteillet","year":"2018","unstructured":"Monteillet L, Gjorgjieva M, Silva M, Verzieux V, Imikirene L, Duchampt A, et al. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context. Mol Metab. 2018;16:100\u201315.","journal-title":"Mol Metab"},{"issue":"1","key":"729_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/hmg\/ddy343","volume":"28","author":"LR Waskowicz","year":"2019","unstructured":"Waskowicz LR, Zhou J, Landau DJ, Brooks ED, Lim A, Yavarow ZA, Kudo T, Zhang H, Wu Y, Grant S, Young SP, Huat BB, Yen PM, Koeberl DD. Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia. Hum Mol Genet. 2019;28(1):143\u201354.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"729_CR30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/hmg\/ddz290","volume":"29","author":"ZA Yavarow","year":"2020","unstructured":"Yavarow ZA, Kang HR, Waskowicz LR, Bay BH, Young SP, Yen PM, Koeberl DD. Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia. Hum Mol Genet. 2020;29(2):286\u201394.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"729_CR31","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/hmg\/ddab297","volume":"31","author":"L Monteillet","year":"2022","unstructured":"Monteillet L, Labrune P, Hochuli M, Do Cao J, Tortereau A, Miliano AC, et al. Cellular and metabolic effects of renin-angiotensin system blockade on glycogen storage disease type I nephropathy. Hum Mol Genet. 2022;31(6):914\u201328.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"729_CR32","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1021\/acs.jproteome.9b00309","volume":"18","author":"D Cangelosi","year":"2019","unstructured":"Cangelosi D, Resaz R, Petretto A, Segalerba D, Ognibene M, Raggi F, et al. A Proteomic Analysis of GSD-1a in Mouse Livers: Evidence for Metabolic Reprogramming, Inflammation, and Macrophage Polarization. J Proteome Res. 2019;18(7):2965\u201378.","journal-title":"J Proteome Res"},{"issue":"5","key":"729_CR33","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1002\/hep.32022","volume":"74","author":"MGS Rutten","year":"2021","unstructured":"Rutten MGS, Derks TGJ, Huijkman NCA, Bos T, Kloosterhuis NJ, van de Kolk KCWA, et al. Modeling Phenotypic Heterogeneity of Glycogen Storage Disease Type 1a Liver Disease in Mice by Somatic CRISPR\/CRISPR-associated protein 9-Mediated Gene Editing. Hepatology. 2021;74(5):2491\u2013507.","journal-title":"Hepatology"},{"issue":"9","key":"729_CR34","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/oby.2009.510","volume":"18","author":"SJ Mihalik","year":"2010","unstructured":"Mihalik SJ, Goodpaster BH, Kelley DE, Chace DH, Vockley J, Toledo FG, DeLany JP. Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity (Silver Spring). 2010;18(9):1695\u2013700.","journal-title":"Obesity (Silver Spring)"},{"issue":"60","key":"729_CR35","doi-asserted-by":"publisher","first-page":"33554","DOI":"10.3402\/fnr.v60.33554","volume":"23","author":"R D\u00edaz-R\u00faa","year":"2016","unstructured":"D\u00edaz-R\u00faa R, Palou A, Oliver P. Cpt1a gene expression in peripheral blood mononuclear cells as an early biomarker of diet-related metabolic alterations. Food Nutr Res. 2016;23(60):33554.","journal-title":"Food Nutr Res"},{"issue":"1","key":"729_CR36","doi-asserted-by":"publisher","first-page":"18329","DOI":"10.1038\/s41598-021-96981-6","volume":"11","author":"A Costa","year":"2021","unstructured":"Costa A, Reyn\u00e9s B, Konieczna J, Mart\u00edn M, Fiol M, Palou A, Romaguera D, Oliver P. Use of human PBMC to analyse the impact of obesity on lipid metabolism and metabolic status: a proof-of-concept pilot study. Sci Rep. 2021;11(1):18329.","journal-title":"Sci Rep"},{"issue":"3","key":"729_CR37","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cmet.2019.07.004","volume":"30","author":"DA Nicholas","year":"2019","unstructured":"Nicholas DA, Proctor EA, Agrawal M, Belkina AC, Van Nostrand SC, Panneerseelan-Bharath L, et al. Fatty Acid Metabolites Combine with Reduced \u03b2 Oxidation to Activate Th17 Inflammation in Human Type 2 Diabetes. Cell Metab. 2019;30(3):447-461.e5.","journal-title":"Cell Metab"},{"issue":"8","key":"729_CR38","doi-asserted-by":"publisher","first-page":"e1003186","DOI":"10.1371\/journal.pcbi.1003186","volume":"9","author":"K van Eunen","year":"2013","unstructured":"van Eunen K, Simons SM, Gerding A, Bleeker A, den Besten G, Touw CM, Houten SM, Groen BK, Krab K, Reijngoud DJ, Bakker BM. Biochemical competition makes fatty-acid \u03b2-oxidation vulnerable to substrate overload. PLoS Comput Biol. 2013;9(8):e1003186.","journal-title":"PLoS Comput Biol"},{"issue":"7","key":"729_CR39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11892-015-0611-8","volume":"15","author":"K Stadler","year":"2015","unstructured":"Stadler K, Goldberg IJ, Susztak K. The evolving understanding of the contribution of lipid metabolism to diabetic kidney disease. Curr Diab Rep. 2015;15(7):40.","journal-title":"Curr Diab Rep"},{"issue":"14","key":"729_CR40","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1177\/1535370220928276","volume":"245","author":"J Wang","year":"2020","unstructured":"Wang J, Chen Y, Song Q, Griffiths A, Song Z. mTORC1-IRE1\u03b1 pathway activation contributes to palmitate-elicited triglyceride secretion and cell death in hepatocytes. Exp Biol Med (Maywood). 2020;245(14):1268\u201379.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"729_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40659-019-0253-4","volume":"52","author":"SK Marafie","year":"2019","unstructured":"Marafie SK, Al-Shawaf EM, Abubaker J, Arefanian H. Palmitic acid-induced lipotoxicity promotes a novel interplay between Akt-mTOR, IRS-1, and FFAR1 signaling in pancreatic \u03b2-cells. Biol Res. 2019;52(1):44.","journal-title":"Biol Res"},{"issue":"7","key":"729_CR42","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.3390\/ijms19072043","volume":"19","author":"Z Mao","year":"2018","unstructured":"Mao Z, Zhang W. Role of mTOR in Glucose and Lipid Metabolism. Int J Mol Sci. 2018;19(7):2043.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"729_CR43","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1017\/S0007114516002993","volume":"116","author":"UJ Jung","year":"2016","unstructured":"Jung UJ, Seo YR, Ryu R, Choi MS. Differences in metabolic biomarkers in the blood and gene expression profiles of peripheral blood mononuclear cells among normal weight, mildly obese and moderately obese subjects. Br J Nutr. 2016;116(6):1022\u201332.","journal-title":"Br J Nutr"},{"issue":"9","key":"729_CR44","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/hmg\/ddh109","volume":"13","author":"MI Ekstrand","year":"2004","unstructured":"Ekstrand MI, Falkenberg M, Rantanen A, Park CB, Gaspari M, Hultenby K, Rustin P, Gustafsson CM, Larsson NG. Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum Mol Genet. 2004;13(9):935\u201344.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"729_CR45","doi-asserted-by":"publisher","first-page":"e0119687","DOI":"10.1371\/journal.pone.0119687","volume":"10","author":"M Ikeda","year":"2015","unstructured":"Ikeda M, Ide T, Fujino T, Arai S, Saku K, Kakino T, et al. Overexpression of TFAM or twinkle increases mtDNA copy number and facilitates cardioprotection associated with limited mitochondrial oxidative stress. PLoS ONE. 2015;10(3):e0119687.","journal-title":"PLoS ONE"},{"issue":"6","key":"729_CR46","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.cmet.2012.10.016","volume":"16","author":"C Vernochet","year":"2012","unstructured":"Vernochet C, Mourier A, Bezy O, Macotela Y, Boucher J, Rardin MJ, et al. Adipose-specific deletion of TFAM increases mitochondrial oxidation and protects mice against obesity and insulin resistance. Cell Metab. 2012;16(6):765\u201376.","journal-title":"Cell Metab"},{"issue":"8","key":"729_CR47","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.2337\/db19-0088","volume":"68","author":"JH Koh","year":"2019","unstructured":"Koh JH, Johnson ML, Dasari S, LeBrasseur NK, Vuckovic I, Henderson GC, et al. TFAM Enhances Fat Oxidation and Attenuates High-Fat Diet-Induced Insulin Resistance in Skeletal Muscle. Diabetes. 2019;68(8):1552\u201364.","journal-title":"Diabetes"},{"issue":"5","key":"729_CR48","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1093\/hmg\/ddaa007","volume":"29","author":"S Gautam","year":"2020","unstructured":"Gautam S, Zhang L, Arnaoutova I, Lee C, Mansfield BC, Chou JY. The signaling pathways implicated in impairment of hepatic autophagy in glycogen storage disease type Ia. Hum Mol Genet. 2020;29(5):834\u201344.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"729_CR49","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/mnfr.201100685","volume":"56","author":"VD de Mello","year":"2012","unstructured":"de Mello VD, Kolehmanien M, Schwab U, Pulkkinen L, Uusitupa M. Gene expression of peripheral blood mononuclear cells as a tool in dietary intervention studies: What do we know so far? Mol Nutr Food Res. 2012;56(7):1160\u201372.","journal-title":"Mol Nutr Food Res"}],"container-title":["Genes &amp; Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12263-023-00729-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12263-023-00729-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12263-023-00729-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:49:28Z","timestamp":1686098968000},"score":1,"resource":{"primary":{"URL":"https:\/\/genesandnutrition.biomedcentral.com\/articles\/10.1186\/s12263-023-00729-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,6]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["729"],"URL":"https:\/\/doi.org\/10.1186\/s12263-023-00729-y","relation":{},"ISSN":["1555-8932","1865-3499"],"issn-type":[{"value":"1555-8932","type":"print"},{"value":"1865-3499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,6]]},"assertion":[{"value":"21 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee of the Universita` di Napoli \u201cFederico II, protocol number 151\/05.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}